Executive summary
Introduction
The ever-increasing cost of medication is a central concern in many forums. The media and the politicians have not failed to notice it either. Over 25 bills and numerous committees were set up to investigate the matter in 2017. While the issue of pricing has not attracted homogenous views, the efforts to increase competition on the market have drawn attention from across the divide. The FDA Reauthorization Act of 2017, which sailed through in both houses quite easily, identified quick route to allow some generics if it is determined by the secretary that the generic competition is not adequate (Mody and Blackwood, 2018). In the recent Health, Pensions, Labour and Education by the Senate hearing, members from both sides agreed with the need for competition and to thwart anti competition practices. They agreed that it was important to introduce generics and biosimilars to the market whenever it is determined appropriate to do so. They also mentioned that pay-for delay agreements should be abolished.
Approaches and results
i. Improving price transparency
While increasing transparency will not by itself fully reduce the price of prescription drugs, laws that enforce transparency practices are still required. Such laws will not only shame pharmaceutical dealers who increase prices without due consideration but also lay a basis for future reform in the sector. The bills before the houses in the various states differ in their utility and thoroughness. The states of...
References
Benavides, L. R. (2018). 2017 Legislative Recap: Important Bills from Nevada's 79th Legislative Session. In Nevada Law Journal Forum (Vol. 2, No. 1, p. 4).
Cox, C., Kamal, R., Jankiewicz, A. & Rousseau, D. (2016). Recent trends in prescription drug costs. JAMA, 315(13):1326.
Huelskoetter, T. (2018). State Policies to Address Prescription Drug Prices. Center for American Progress.
Mody, P.R. and Blackwood, K. (2018). 5 Health Care Policy Issues to Follow In 2018. Arnord & Porter. Retrieved from https://www.arnoldporter.com/en/perspectives/publications/2018/01/5-health-care-policy-issues-to-follow-in-2018 on 8 November 2018
It is however important to note that the effectiveness of such a prevention plan is largely dependent on how well it is implemented. In my view, the successful implementation of the plan could see the country freed from the menace of prescription drug abuse. Apart from OxyContin, which is essentially a narcotic painkiller, the other prescription drugs which are commonly abused according to the National Institute on Drug Abuse
1). Taking drugs for longer than medically necessary, asking multiple physicians for drugs, or simply accepting medications for which they are over-prescribed by irresponsible physicians can all shape the pattern of elderly person's prescription drug abuse. Taking prescription drugs with alcohol or drugs that are contraindicated with their medications is another. Drugs with psychoactive properties may be more prescribed amongst the elderly, because it is assumed they are less likely
Prescription Drug Abuse: Narcotics In today's society, the debate as to whether or not prescription narcotics are necessary in certain situations is one that is fueled mainly be the tendency for patients to overuse after being prescribed these medications. In many situations, patients present with pain that is treated by their respective physicians with prescriptions drugs that fall into the category of narcotics and opiates in order for the cited pain
Usually, both physical and psychological components need to be addressed. Byrd (2001) explains, the function of brain cells (neurons) is affected when a drug is used repeatedly over a long period of time. Each neuron produces and releases chemicals called neurotransmitters. These neurotransmitters can impact the function of the nerve cell, making it produce and release hormones. "The neurotransmitters that have been associated with addiction include serotonin, dopamine, norepinephrine,
The FDA also, amongst others, has recommended that clinical trials used to support advertising claims be approved by the FDA and to institute stiff fines against those found gaily of deceptive tactics. (Turning Medicine Into Snake Oil...) There is little doubt from the research that pharmaceutical companies have to be made more accountable for their products and advertising promises. References Borden Anne. Vioxx Stroke Risk could last for Years. 2007. Retrieved
Prescriptions are everywhere, and even adult prescriptions are easily accessed by youth abusing the wide variety of drugs. The 2003 National Survey on Drug Use and Health (NSDUH) found four percent of America's youth "ages 12 to 17 reported nonmedical use of prescription medications in the past month," (National Institute on Drug Abuse 1). Children given medications at a young age also have a greater chance of developing later
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now